Home > > > Report Detail

Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future

Publisher Name :
Date: 23-Dec-2019
No. of pages: 74

Report Includes:

- An overview of top five opportunities for generic or biosimilar drugs in pharmaceuticals market 2019

- Coverage of generics and discussion on their characteristics

- Information on Hatchmann-Wax act and its effect on market competitiveness impacting pricing and development of original drugs

- Insights on the key challenges and opportunities in the development of generics or biosimilar drugs

- Description of product class, mechanism of action, indications and contraindications,

- Clinical and generic development of the prominent products

- Detailed patent analysis i.e. expiry and exclusivity, regulations and policies and patent expiry and market impact

- Profiles of key competitors engaged in the development of generic and biosimilars

Summary

The global pharmaceutical market is estimated to be valued at $1.5 trillion by 2020 and witnessing a growth of 4-5%. In the last 3 decades the pharmaceutical market witnessed a shift from a blockbuster model to new business models owing to the influx of generic drugs. Generic basically mimic the original drug characteristics and show equivalence in therapeutic effect. However, these class of drugs are cheaper and are easy to scale up when compared to original branded drugs. This change in the business model is attributed to formulation of the Hatchmann-Wax act in 1984 as a federal law that encouraged manufacture and sale of generic version of the original branded drugs. The act provided some exclusivity rights to the original branded drug developers and generic manufacturers to file their application for abbreviated new drug application (ANDA). This increased competitiveness in the industry and provided avenues for patient population who are have limited access to medicines. Because of this an original branded drug that lost its exclusivity rights becomes a target of generic manufacturer to scale up a generic version and reduce the market share of the original drugs. Therefore, patent expiry rates have key drivers of generic drug development, manufacture and marketing.

Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Methodology
Analyst's Credentials

Chapter 2 Perspectives of Generics and Biosimilar Business
Overview of Generics and Biosimilars
Generics
Types of Generics
Biosimilars
Lifecycle of a Biosimilar Drug
Development of a Biosimilar
Manufacturing of a Biosimilar
Preclinical Studies and Validation of a Biosimilar
Clinical Trials
Generics vs. Biosimilars
Market Landscape of Generics and Biosimilars
Competitive Landscape of Generics and Biosimilars
Trends
Structure of the Generics Industry
Biosimilars Competitive Landscape
Bio-intellectual Companies
Opportunistic Companies
Emerging Trends in Biosimilar Industry Structure

Chapter 3 Patents & Patent Cliffs
Patents and IP
Supplementary Protection Certificates
Patent Regulations in Favor of Branded Biologics
Patent Regulations in Favor of Biosimilars-Emerging Trends

Chapter 4 Regulation of Generics and Biosimilars Business
United States
European Union
EU Marketing Authorization Systems
Types of Applications
Regulation of Biosimilars
EU Provisions
Evolving Situation in the U.S.
User Fees
Defensive Strategies by "Big Pharma"
Authorized Generics
User Fees
Changing Climate for Generics
Situation in Europe

Chapter 5 Product Profile Analysis
Overview
Profile Analysis
Xolair
Mechanism of Action
Indications and Contraindication
Dosage and Administration
Historical Net Sales and Growth Rates of Xolair for Novartis
Timeline of Key Events-Xolair (Omalizumab)
Key Regulatory Approvals
Pricing and Annual Cost of Xolair Associated with Treatment
Factors Favoring Generic/Biosimilar Development of Xolair
Biosimilar Clinical Developments
Profiles Key Companies engaged in the Business/Development of Xolair and Biosimilar Omalizumab
Companies Developing Biosimilar Version of Omalizumab
Revlimid
Mechanism of Action
Indications and Contraindication
Dosage and Administration
Historical Net Sales and Growth Rates
Timeline of Key Events-Revlimide (Lenalilomide)
Pricing and Annual Cost of Revlimid Associated with Treatment
Factors Influencing Generic Development
Business & Legal Challenges
FDA's Campaign of "Naming and Shaming of Branded Pharmaceuticals Adopting Anti-Trade Practices"
Revlimid Generics Development/Marketed Drugs
Company Profiles
Generic Manufacturers of Revlimid
Orencia
Mechanism of Action
Indications and Contraindication
Dosage and Administration
Historical Net Sales and Growth Rates of Orencia for Bristol-Meyers Squibb
Timeline of Key Events-Orencia
Pricing and Annual Cost of Orencia Associated with Treatment
Factors Favoring Generic/Biosimilar Development of Orencia
Biosimilar Clinical Developments
Profiles Key Companies Engaged in the Business/Development of Xolair and Biosimilar Omalizumab
Companies Developing Biosimilar Version of Omalizumab
Pradaxa
Mechanism of Action
Indications
Adverse Reaction
Dosage and Administration
Historical Net Sales and Growth Rates of Pradaxa
Clinical Development
Timeline of Key Events-Pradaxa (Dabigatran)
Pricing and Annual Cost of Pradaxa
Factors Favoring Generic Development of Pradaxa
Generics Clinical Developments
Profiles of the Pradaxa Manufacturer
Generic Manufacturer of Pradaxa
Gilenya
Mechanism of Action
Indications
Dosage and Administration
Historical Net Sales and Growth Rates of Gilenya for Novartis
Timeline of Key Events-Gilenya
Pricing and Annual Cost of Gilenya Associated with Treatment
Factors Favoring Generic/Biosimilar Development of Gilenya
Generic Clinical Developments
Profiles Key Companies Engaged in the Business/Development of Gilenya
Companies Developing Generic Version of Gilenya

Chapter 6 Conclusion
Improved Understanding of Pharmaceutical Technologies
Access to Pharmaceutical Technologies and Production Methods
Shift in the Business Model of Pharmaceutical Industry
Challenges
Future Perspectives

List of Tables
Table 1 : List of Biosimilars Produced in E. Coli
Table 2 : List of Biosimilars Produced in Mammalian Cells
Table 3 : Number of Approved Biosimilars, by Type
Table 4 : Generics vs. Biosimilars
Table 5 : List of Key Products
Table 6 : Sales of Xolair, Through 2018
Table 7 : Approved Indications for Use of Revlimid
Table 8 : Sales of Revlimid, Through 2018
Table 9 : Dosage Recommendation Per Patient Weight
Table 10 : Sales of Orencia, Through 2018
Table 11 : Sales of Pradaxa, Through 2018
Table 12 : Sales of Gilenya, Through 2018

List of Figures
Figure 1 : Xolair Key Events, 2003-2018, Post 2020
Figure 2 : Revlimid Key Events, 2005-2019
Figure 3 : Orencia Key Events, 2005-2019
Figure 4 : Pradaxa Key Events, 2008-2017
Figure 5 : Gilenya Key Events, 2010-2019
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs